M. Gursel

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Gursel, M. Gursel, Mayda Gursel
Publication record
93 papers · 9,683 citations · H-index 37

PAPERS

A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine.
20254 citationsauthor #19
Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine.
20246 citationsauthor #9
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesicles.
20242 citationsauthor #18
Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic
20236 citationsauthor #7
Testing in times of COVID-19: legacy & unfinished agenda
20230 citationsauthor #6
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation
202319 citationsauthor #11
Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency
202224 citationsauthor #22
Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemia
20225 citationsauthor #12
Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency
20229 citationsauthor #27
Why vaccinate children against COVID-19?
20221 citationsauthor #6
Should we vaccinate against long-COVID?
20222 citationsauthor #6
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
202137 citationsauthor #12
Correcting COVID-19 vaccine misinformation
202158 citationsauthor #6
Urgent needs to accelerate the race for COVID-19 therapeutics
202110 citationsauthor #8
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed
202114 citationsauthor #7
Operation Warp Speed: implications for global vaccine security
202191 citationsauthor #8
Metadata of the article that will be visualized in OnlineFirst ArticleTitle Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency
20210 citationsauthor #2
Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
202117 citationsauthor #7
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic
202161 citationsauthor #7
COVID‐19 Vaccine Inequity: High time to calibrate the global moral compass
20213 citationsauthor #1
Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection
202147 citationsauthor #38
Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
2021108 citationsauthor #8
The silent and dangerous inequity around access to COVID-19 testing: A call to action
202147 citationsauthor #9
Activation of Macrophages by CpG DNA and LPS: an FTIR Spectroscopic Study
20201 citationsauthor #4
Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor Cells
202060 citationsauthor #12
Global BCG Vaccination Coverage versus Cases and Mortality in the SARS-CoV-2 Pandemic
20200 citationsauthor #1
Data for: Activation of Macrophages by CpG DNA and LPS: an FTIR Spectroscopic Study
20201 citationsauthor #4
ATR FTIR Spectoscopy of Aqueous Cell Cultures v2
20201 citationsauthor #4
Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
202052 citationsauthor #1
Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?
2020115 citationsauthor #1
Dual-adjuvant effect of PH-sensitive liposomes loaded with sting and TLR9 agonists regress tumor development by enhancing TH1 immune response.
202062 citationsauthor #7
A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathway.
20199 citationsauthor #8
Type I IFN–related NETosis in ataxia telangiectasia and Artemis deficiency
201755 citationsauthor #22
Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet’s disease severity
201719 citationsauthor #8
Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction
201713 citationsauthor #5
Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development
201759 citationsauthor #5
Intestinal Microbiota in Patients with Spinal Cord Injury
2016141 citationsauthor #5
Development of CpG ODN Based Vaccine Adjuvant Formulations.
201618 citationsauthor #1
Use of CpG Oligonucleotides as Mucosal Adjuvants
20157 citationsauthor #1
Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell‐penetrating peptide or combined with CpG
201535 citationsauthor #7
Biological properties of extracellular vesicles and their physiological functions
20155,000 citationsauthor #23
STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children
20159 citationsauthor #3
CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity
201477 citationsauthor #9
P602 REVERSING THE PROGRESS OF LIVER FIBROSIS USING MEMBRANE VESICLES SECRETED FROM COMMENSAL BACTERIA
20140 citationsauthor #3
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
20147 citationsauthor #4
Immune Activation Effect of Suppressive DNA on CpG-Induced
20130 citationsauthor #3
ActivationBacterial DNA-Induced Immune Repetitive Elements in Mammalian Telomeres
20130 citationsauthor #4
Activationof CpG-Induced Immune CXCL16 Influences the Nature and
20130 citationsauthor #2
Activity of CpG Oligonucleotides Improve the Uptake and Immunostimulatory Sterically Stabilized Cationic Liposomes
20130 citationsauthor #2
Plasmacytoid Dendritic Cell Response to CpG ODN Correlates with CXCL16 Expression and Is Inhibited by ox-LDL
20133 citationsauthor #1
Activation of type I interferon‐dependent genes characterizes the “core response” induced by CpG DNA
201225 citationsauthor #4
Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes.
201144 citationsauthor #2
Mammalian Telomeric DNA Suppresses Endotoxin-induced Uveitis*
201012 citationsauthor #3
Rapid differentiation of MSC into adipocytes and osteocytes is facilitated by Toll-Like receptor engagement (136.43)
20100 citationsauthor #4
Immune regulatory roles of microparticles in autoimmune and allergic diseases (87.22)
20100 citationsauthor #3
Immunoregulatory Activities of Self-Nanoparticle Forming CpG ODN (89.52)
20100 citationsauthor #4
Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety
200921 citationsauthor #7
CXCL16 Influences the Nature and Specificity of CpG-Induced Immune Activation12
200690 citationsauthor #1
Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors
200565 citationsauthor #3
Suppressive Oligodeoxynucleotides Protect Mice from Lethal Endotoxic Shock1
200596 citationsauthor #3
CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+ monocytes.
20053 citationsauthor #2
Mice from Lethal Endotoxic Shock Suppressive Oligodeoxynucleotides Protect
20050 citationsauthor #2
Monocytes + CD11c+ Human CD14 Single-Stranded RNA That Stimulates CpG RNA: Identification of Novel
20050 citationsauthor #2
CpG Oligodeoxynucleotides Enhance Neonatal Resistance to Listeria Infection
200563 citationsauthor #3
CpG RNA: Identification of Novel Single-Stranded RNA That Stimulates Human CD14+CD11c+ Monocytes
200586 citationsauthor #2
This information is current as Infection Listeria Neonatal Resistance to CpG Oligodeoxynucleotides Enhance
20040 citationsauthor #3
Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.
200455 citationsauthor #3
Suppressive Oligodeoxynucleotides Inhibit Th1 Differentiation by Blocking IFN-γ- and IL-12-Mediated Signaling1
200489 citationsauthor #2
Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9.
2004200 citationsauthor #5
IL-12-Mediated Signaling - and g Th1 Differentiation by Blocking IFN-Suppressive Oligodeoxynucleotides Inhibit
20040 citationsauthor #2
Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis.
200374 citationsauthor #3
Repetitive Elements in Mammalian Telomeres Suppress Bacterial DNA-Induced Immune Activation1
2003260 citationsauthor #2
Infection Leishmania and SIV-Infected Macaques from CpG Oligodeoxynucleotides Protect Normal
20030 citationsauthor #6
Regulation of CpG‐Induced Immune Activation by Suppressive Oligodeoxynucleotides
200339 citationsauthor #4
CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection1
2003120 citationsauthor #2
ActivationSuppress Bacterial DNA-Induced Immune Repetitive Elements in Mammalian Telomeres
20030 citationsauthor #4
Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides.
200332 citationsauthor #6
Effect of Suppressive DNA on CpG-Induced Immune Activation1
2002131 citationsauthor #6
Potential Role of Phosphatidylinositol 3 Kinase, rather than DNA-dependent Protein Kinase, in CpG DNA–induced Immune Activation
2002151 citationsauthor #4
CpG DNA: recognition by and activation of monocytes.
200282 citationsauthor #7
CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells
200299 citationsauthor #1
Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs1 2
2001343 citationsauthor #3
DNA-Induced Activation of Human Cells Cutting Edge : Role of Toll-Like Receptor 9 in
20011 citationsauthor #2
Sterically Stabilized Cationic Liposomes Improve the Uptake and Immunostimulatory Activity of CpG Oligonucleotides1
2001191 citationsauthor #2
MotifsRecognize and Respond to Two Distinct CpG Human Peripheral Blood Cells Differentially
20010 citationsauthor #3
Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1
2001645 citationsauthor #6
Human Peripheral Blood Cells Differentially Recognize and Respond to Two Distinct CpG Motifs
2001237 citationsauthor #3
Immunotherapeutic applications of CpG-containing oligodeoxynucleotides.
20007 citationsauthor #3
The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles.
19986 citationsauthor #1
The Immunological Co-Adjuvant Action of Liposomal Interleukin-15
19970 citationsauthor #1
Liposomes As Immunological Adjuvants and Vaccine Carriers
199695 citationsauthor #3
A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery.
199527 citationsauthor #3
Use of liposomes and cytokines as immunological adjuvants in vaccines.
19950 citationsauthor #1

TIMELINE

1995 27 citations

1996 95 citations

1997 0 citations

1998 6 citations

2000 7 citations

2001 1,417 citations

2002 463 citations

2003 525 citations

2004 344 citations

2005 313 citations

2006 90 citations

2009 21 citations

2010 12 citations

2011 44 citations

2012 25 citations

2013 3 citations

2014 84 citations

2015 5,051 citations

2016 159 citations

2017 146 citations

2019 9 citations

2020 292 citations

2021 493 citations

2022 41 citations

2023 25 citations

2024 8 citations

2025 4 citations

COAUTHOR MAP

CONCEPT FOOTPRINT